Proteomic analysis of post-nuclear supernatant fraction and percoll-purified membranes prepared from brain cortex of rats exposed to increasing doses of morphine

Proteome Science

Volumn 12, Issue 1, 2014, Pages

  Ujcikova, Hana ^a   Eckhardt, Adam ^a   Kagan, Dmytro ^a   Roubalova, Lenka ^a   Svoboda, Petr ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

2D electrophoresis; Fore brain cortex; Isolated plasma membranes; Long term adaptation; Morphine; Post nuclear supernatant

Indexed keywords

ASPARTATE AMINOTRANSFERASE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLUTAMATE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROLASE; KHELLIN; MALATE DEHYDROGENASE; MORPHINE; N ETHYLMALEIMIDE SENSITIVE FACTOR; PEROXIREDOXIN 2; PROHIBITIN; PROTEIN DISULFIDE ISOMERASE; RIBOSOME PROTEIN; SEPTIN; SIRTUIN 2; UBIQUITIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL DEATH; CELL FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; DRUG DOSE INCREASE; ENDOPLASMIC RETICULUM; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE; MYELIN SHEATH; NONHUMAN; OXIDATIVE STRESS; POST NUCLEAR SUPERNATANT; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; RAT; SIGNAL TRANSDUCTION; SUPERNATANT; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

RATTUS;

EID: 84896719312     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-12-11     Document Type: Article

References (70)

1. Contet C, Kieffer BL, Befort K. Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 2004, 14:370-378. 10.1016/j.conb.2004.05.005, 15194118.
2. Preston KL. Drug abstinence effects: opioids. Br J Addict 1991, 86:1641-1646. 10.1111/j.1360-0443.1991.tb01759.x, 1786495.
3. Connor M, Christie MD. Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol 1999, 26:493-499. 10.1046/j.1440-1681.1999.03049.x, 10405772.
4. Law PY, Wong YH, Loh HH. Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 2000, 40:389-430. 10.1146/annurev.pharmtox.40.1.389, 10836142.
5. Law PY, Loh HH, Wei LN. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 2004, 47:300-311.
6. Robinson TE, Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 1999, 33:160-162. 10.1002/(SICI)1098-2396(199908)33:2<160::AID-SYN6>3.0.CO;2-S, 10400894.
7. Li KW, Jimenez CR, van der Schors RC, Hornshaw MP, Schoffelmeer ANM, Smit AB. Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics 2006, 6:2003-2008. 10.1002/pmic.200500045, 16447156.
8. Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ, Ho IK. Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 2005, 133:58-70. 10.1016/j.molbrainres.2004.09.018, 15661365.
9. Miller AL, Hawkins RA, Harris RL, Veech RL. The effects of acute and chronic morphine treatment and of morphine withdrawal on rat brain in vivo. Biochem J 1972, 129:463-469. 1174096, 4674603.
10. Li Q, Zhao X, Zhong LJ, Yang HY, Wang Q, Pu XP. Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia. Eur J Pharmacol 2009, 612:21-28. 10.1016/j.ejphar.2009.03.049, 19345208.
11. Bourova L, Vosahlikova M, Kagan D, Dlouha K, Novotny J, Svoboda P. Long-term adaptation to high doses of morphine causes desensitization of μ-OR- and δ-OR-stimulated G-protein response in forebrain cortex but does not decrease the amount of G-protein alpha subunit. Med Sci Monit 2010, 16:260-270.
12. Ujcikova H, Dlouha K, Roubalova L, Vosahlikova M, Kagan D, Svoboda P. Up-regulation of adenylylcyclases I and II induced by long-term adaptation of rats to morphine fades away 20 days after morphine withdrawal. Biochim Biophys Acta 1810, 2011:1220-1229.
13. Paletzki RF. Cloning and characterization of guanine deaminase from mouse and rat brain. Neuroscience 2002, 109:15-26. 10.1016/S0306-4522(01)00352-9, 11784697.
14. Toei M, Saum R, Forgac M. Regulation and isoform function of the V-ATPases. Biochemistry 2010, 49:4715-4723. 10.1021/bi100397s, 2907102, 20450191.
15. Tanaka S, Uehara T, Nomura Y. Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Bioch Chem 2000, 275:10388-10393.
16. Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, Eisenhauer PB, Fine RE, Wells JM. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res 2004, 1022:164-172. 10.1016/j.brainres.2004.07.026, 15353226.
17. Drabik A, Bierczynska-Krzysik A, Bodzon-Kulakowska A, Suder P, Kotlinska J, Silberring J. Proteomics in neurosciences. Mass Spectrom Rev 2007, 26:432-450. 10.1002/mas.20131, 17405153.
18. Abul-Husn NS, Annangudi SP, Ma'ayan A, Ramos-Ortolaza DL, Stockton SD, Gomes I, Sweedler JV, Devi LA. Chronic morphine alter the presynaptic protein profile: identification of novel molecular targets using proteomics and network analysis. PLoS One 2011, 6:e25535. 10.1371/journal.pone.0025535, 3197197, 22043286.
19. Shi Q, Gibson GE. Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress in mediated by miR-743a. J Neurochem 2011, 118:440-448. 10.1111/j.1471-4159.2011.07333.x, 3135703, 21623795.
20. Chuang DM, Hough C, Senatorov VV. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 2005, 45:269-290. 10.1146/annurev.pharmtox.45.120403.095902, 15822178.
21. Hwang NR, Yim SH, Kim YM, Jeong J, Song EJ, Lee Y, Choi S, Lee KJ. Oxidative modifications of glyceraldehyde-3-phophate dehydrogenase play a key role in its multiple cellular functions. Biochem J 2009, 423:253-264. 10.1042/BJ20090854, 19650766.
22. Koppitz B, Vogel F, Mayr GW. Mammalian aldolases are isomer-selective high-affinity inositol polyphosphate binders. Eur J Biochem 1986, 161:421-433. 10.1111/j.1432-1033.1986.tb10462.x, 3780751.
23. Baron CB, Tolan DR, Choi KH, Coburn RF. Aldolase A Ins(1,4,5)P3-binding domains as determined by site-directed mutagenesis. Biochem J 1999, 341:805-812. 10.1042/0264-6021:3410805, 1220421, 10417347.
24. Hua LV, Green M, Warsh JJ, Li PP. Lithium regulation of aldolase A expression in the rat frontal cortex: identification by differential display. Biol Psychiatry 2000, 48:58-64. 10.1016/S0006-3223(00)00824-6, 10913508.
25. Shen W, Willis D, Zhang Y, Schlattner U, Wallimann T, Molloy GR. Expression of creatine kinase isoenzyme genes during postnatal development of rat brain cerebellum:evidence for transcriptional regulation. Biochem J 2002, 367:369-380. 10.1042/BJ20020709, 1222886, 12093362.
26. Perluigi M, Poon HF, Maragos W, Pierce WM, Klein JB, Calabrese V, Cini C, De Marco C, Butterfield DA. Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice. Mol Cell Proteomics 2005, 4:1849-1861. 10.1074/mcp.M500090-MCP200, 15968004.
27. Kashihara M, Miyata S, Kumanogoh H, Funatsu N, Matsunaga W, Kiyohara T, Sokawa Y, Maekawa S. Changes in the localization of NAP-22, a calmodulin binding membrane protein, during the development of neuronal polarity. Neurosci Res 2000, 37:315-325. 10.1016/S0168-0102(00)00132-2, 10958980.
28. Okae H, Iwakura Y. Neural tube defects and impaired neural progenitor cell proliferation in Gβ1-deficient mice. Dev Dyn 2010, 239:1089-1101. 10.1002/dvdy.22256, 20186915.
29. Sunahara RK, Taussig R. Isoforms of mammalian adenylylcyclase: multiplicities of signaling. Mol Interv 2002, 2:168-184. 10.1124/mi.2.3.168, 14993377.
30. Wang HY, Burns LH. Gβγ that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein. J Neurobiol 2006, 12:1302-1310.
31. Perluigi M, Domenico FD, Giorgi A, Shininà ME, Coccia R, Cini C, Bellia F, Cambria MT, Cornelius C, Butterfield DA, Calabrese V. Redox proteomics in aging rat brain involvement of mitochondrial reduced glutathione status and mitochondrial protein oxidation in the aging process. J Neurosci Res 2010, 88:3498-3507. 10.1002/jnr.22500, 20936692.
32. Kaplan MP, Chin SSM, Fliegner KH, Liem RKH. α-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J Neurosci 1990, 10:2735-2748.
33. Wu A, Ying Z, Gomez-Pinilla F. Oxidative stress modulates Sir2α in rat hippocampus and cerebral cortex. Eur J Neurosci 2006, 22:5213-5216.
34. Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. The role of α-synuclein in Parkinson's disease: insights from animal models. Nat Rev Neurosci 2003, 4:727-738. 10.1038/nrn1199, 12951565.
35. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005, 38:1543-1552. 10.1016/j.freeradbiomed.2005.02.026, 15917183.
36. Woodman PG. p97, a protein coping with multiple identities. J Cell Sci 2003, 116:4283-4290. 10.1242/jcs.00817, 14514884.
37. Wang HF, Shih YT, Chen CY, Chao HW, Lee MJ, Hsueh YP. Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. J Clin Invest 2011, 121:4820-4837. 10.1172/JCI45677, 3225986, 22105171.
38. Cooper AJL. 13 N as a tracer for studying glutamate metabolism. Neurochem Int 2011, 59:456-464. 10.1016/j.neuint.2010.11.011, 3139761, 21108979.
39. Ohnuki M, Takahashi N, Yamasaki M, Fukui T. Different localization in rat brain of the novel cytosolic ketone body-utilizing enzyme, acetoacetyl-CoA synthetase, as compared to succinyl-CoA:3 -oxoacid CoA-transferase. Biochim Biophys Acta 2005, 1729:147-153. 10.1016/j.bbaexp.2005.05.006, 15992942.
40. Das SK, Hiran KR, Mukherjee S, Vasudevan DM. Oxidative stress is the primary event: effects of ethanol consumption in brain. Indian J Clin Biochem 2007, 22:99-104. 10.1007/BF02912890, 3454264, 23105661.
41. Murphey RK, Godenschwege TA. New roles for ubiquitin in the assembly and function of neuronal circuits. Neuron 2002, 36:5-8. 10.1016/S0896-6273(02)00943-1, 12367500.
42. Artal-Sanz M, Tavernarakis N. Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C.elegans. Nature 2009, 461:793-797. 10.1038/nature08466, 19812672.
43. Merkwirth C, Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009, 1793:27-32. 10.1016/j.bbamcr.2008.05.013, 18558096.
44. Mishra S, Ande SR, Nyomba BL. The role of prohibitin in cell signaling. FEBS J 2010, 277:3937-3946. 10.1111/j.1742-4658.2010.07809.x, 20840588.
45. Zhou P, Qian L, D'Aurelio M, Cho S, Wang G, Manfredi G, Pickel V, Iadecola C. Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J Neurosci 2012, 32:583-592. 10.1523/JNEUROSCI.2849-11.2012, 3287080, 22238093.
46. Tsujita K, Itoh T, Kondo A, Oyama M, Kozuka-Hata H, Irino Y, Hasegawa J, Takenawa T. Proteome of acidic phospholipid-binding proteins: spatial and temporal regulation of coronin 1A by phosphoinositides. J Biol Chem 2010, 285:6781-6789. 10.1074/jbc.M109.057018, 2825472, 20032464.
47. Tada T, Simonetta A, Batterton M, Kinoshita M, Edbauer D, Sheng M. Role of septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Curr Biol 2007, 17:1752-1758. 10.1016/j.cub.2007.09.039, 2194646, 17935993.
48. Traudt CM, Tkac I, Ennis KM, Sutton LM, Mammel DM, Rao R. Postnatal morphine administration alters hippocampal development in rats. J Neurosci Res 2012, 90:307-314. 10.1002/jnr.22750, 3218243, 21971612.
49. Plafker SM, Macara IG. Ribosomal protein L12 uses a distinct nuclear import pathway mediated by importin 11. Mol Cell Biol 2002, 22:1266-1275. 10.1128/MCB.22.4.1266-1275.2002, 134630, 11809816.
50. Filizola M, Devi LA. Structural biology: how opiod drugs bind to receptors. Nature 2012, 485:314-317. 10.1038/485314a, 3589518, 22596150.
51. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, Granier S. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist. Nature 2012, 485:321-326. 10.1038/nature10954, 3523197, 22437502.
52. Sim LJ, Selley DE, Dworkin SI, Childers SR. Effects of chronic morphine administration on μ opioid receptor-stimulated [35S]GTPγS autoradiography in rat brain. J Neurosci 1996, 16:2684-2692.
53. Maher CE, Martin TJ, Childers SR. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration. Life Sci 2005, 77:1140-1154. 10.1016/j.lfs.2005.03.004, 15890372.
54. Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ. Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 2000, 20:4555-4562.
55. Bierczynska-Krzysik A, Bonar E, Drabik A, Noga M, Suder P, Dylag T, Dubin A, Kotlinska J, Silberring J. Rat brain proteome in morphine dependence. Neurochem Int 2006, 49:401-406. 10.1016/j.neuint.2006.01.024, 16581157.
56. Bierczynska-Krzysik A, Pradeep John JP, Silberring J, Kotlinska J, Dylag T, Cabatic M, Lubec G. Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med 2006, 18:775-784.
57. Bodzon-Kułakowska A, Suder P, Mak P, Bierczynska-Krzysik A, Lubec G, Walczak B, Kotlinska J, Silberring J. Proteomic analysis of striatal neuronal cell cultures after morphine administration. J Sep Sci 2009, 32:1200-1210. 10.1002/jssc.200800464, 19296477.
58. Drastichova Z, Bourova L, Hejnova L, Jedelsky P, Svoboda P, Novotny J. Protein alterations induced by long-term agonist treatment of HEK293 cells expressing thyrotropin-releasing hormone receptor and G11α protein. J Cell Biochem 2010, 109:255-264.
59. Kraus MA, Piper JM, Kornetsky C. Persistent increases in basal cerebral metabolic activity induced by morphine sensitization. Pharmacol Biochem Behav 1997, 57:89-100. 10.1016/S0091-3057(96)00117-7, 9164558.
60. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 1999, 354:1155-1163. 10.1098/rstb.1999.0471, 1692634, 10466143.
61. Magistretti PJ, Allaman I. Glycogen: a Trojan horse for neurons. Nat Neurosci 2007, 10:1341-1342. 10.1038/nn1107-1341, 17965648.
62. Guzman DC, Vazquez IE, Brizuela NO, Alvarez RG, Mejia GB, Garcia EH, Santamaria D, La Rosa De Apreza M, Olguin HJ. Assessment of oxidative damage induced by acute doses of morphine sulfate in postnatal and adult rat brain. Neurochem Res 2006, 31:549-554. 10.1007/s11064-006-9053-7, 16758364.
63. Matousek P, Novotny J, Svoboda P. Resolution of G(s)alpha and G(q)alpha/G(11)alpha proteins in membrane domains by two-dimensional electrophoresis: the effect of long-term agonist stimulation. Physiol Res 2004, 53:295-303.
64. Matousek P, Novotny J, Rudajev V, Svoboda P. Prolonged agonist stimulation does not alter the protein composition of membrane domains in spite of dramatic changes induced in a specific signaling cascade. Cell Biochem Biophys 2005, 42:21-40. 10.1385/CBB:42:1:021, 15673926.
65. Moravcova Z, Rudajev V, Stohr J, Novotny J, Cerny J, Parenti M, Milligan G, Svoboda P. Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level. Biochim Biophys Acta 2004, 1691:51-65. 10.1016/j.bbamcr.2003.12.004, 15053924.
66. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999, 20:601-605. 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6, 10217175.
67. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858. 10.1021/ac950914h, 8779443.
68. Sinha P, Poland J, Schnölzer M, Rabilloud T. A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis. Proteomics 2001, 1:835-840. 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.0.CO;2-2, 11503208.
69. Fountoulakis M, Takács MF, Berndt P, Langen H, Takács B. Enrichment of low abundance proteins of Escherichia coli by hydroxyapatite chromatography. Electrophoresis 1999, 20:2181-2195. 10.1002/(SICI)1522-2683(19990801)20:11<2181::AID-ELPS2181>3.0.CO;2-Q, 10493123.
70. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.